Excerpt: “In the interest of ensuring that the funds are directed towards their intended purpose, providing a mechanism where Congress can “see” the development of grants and help direct their constituents to them, and stewarding taxpayer resources in an effective manner, we believe several recent opioid-related legislative packages should be carefully examined to track their destination, assess their impact, and inform our decisions about future efforts,” the members wrote in the letter.
CLICK HERE to read the letter to GAO.